secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001193125-25-195384
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics posts corporate presentation; content not detailed in filing extract
--------------------------------------------------------------------------------

- Corporate presentation posted on Sept 4, 2025, on Lyra Therapeutics website.
- Company ticker: LYRA (NASDAQ). No other specific updates provided in this filing.
- Presentation may be used in investor discussions; details not available from form text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312525195384/0001193125-25-195384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312525195384/d71675d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-195384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer